Literature DB >> 23943235

Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.

Erika F Rodriguez1, Sara E Monaco, Sanja Dacic.   

Abstract

BACKGROUND: The significance of histologic subtyping of surgically resected lung adenocarcinoma (ADC) was recently proposed by the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification. Approximately 70% of lung cancer patients present with advanced disease, and small biopsies or cytology specimens are frequently the only available diagnostic material. It is uncertain whether proposed morphologic subtyping of ADC can be applied to small specimens. The objective of this study was to assess the applicability of morphologic subtyping of ADC on cytologic specimens.
METHODS: Consecutive, newly diagnosed primary lung ADC specimens from patients with matched surgical resection and cytology specimens (n = 66) were selected for the study. The dominant morphologic pattern was determined according to the IASLC/ATS/ERS classification. The number and percentage of malignant cells in cytology specimens were also evaluated.
RESULTS: Concordant subtyping of ADC between the dominant pattern on resection and cytology specimens was observed in 26 cases (40%), and was discordant in 32 cases (48%). Concordance increased in specimens that had >200 cells and when correlating with the primary or secondary histologic pattern. The acinar pattern was the most common in concordant cases, whereas discordant cases had a predominantly solid pattern.
CONCLUSIONS: Application of the IASLC/ATS/ERS ADC classification to cytologic specimens is challenging and depends on the sufficient cellularity of cytologic preparations. The identification of solid and micropapillary patterns is prognostically important but may be unreliable and difficult on cytology specimens. Future studies are needed to establish reproducible cytologic criteria for the precise subtyping of lung ADC on small specimens.
© 2013 American Cancer Society.

Entities:  

Keywords:  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification; adenocarcinoma; adenocarcinoma subtype; cytology; lung

Mesh:

Year:  2013        PMID: 23943235     DOI: 10.1002/cncy.21314

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  12 in total

Review 1.  Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.

Authors:  Ming-Ching Lee; Kyuichi Kadota; Daniel Buitrago; David R Jones; Prasad S Adusumilli
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Authors:  Takashi Eguchi; Kyuichi Kadota; Bernard J Park; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16

3.  The value of cell block based on fine needle aspiration for lung cancer diagnosis.

Authors:  Zhengwei Dong; Hui Li; Jun Zhou; Wei Zhang; Chunyan Wu
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 4.  Histopathologic and molecular approach to staging of multiple lung nodules.

Authors:  Frank Schneider; Sanja Dacic
Journal:  Transl Lung Cancer Res       Date:  2017-10

5.  Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas.

Authors:  Ming-Ching Lee; Daniel H Buitrago; Kyuichi Kadota; David R Jones; Prasad S Adusumilli
Journal:  Lung Cancer Manag       Date:  2014-06-01

Review 6.  Challenges for real-time intraoperative diagnosis of high risk histology in lung adenocarcinoma: A necessity for sublobar resection.

Authors:  Yusuke Takahashi; Hiroaki Kuroda; Yuko Oya; Noriyuki Matsutani; Hirokazu Matsushita; Masafumi Kawamura
Journal:  Thorac Cancer       Date:  2019-07-09       Impact factor: 3.500

7.  Cytological differences between invasive and noninvasive or minimally invasive lung adenocarcinomas diagnosed in Japanese patients using needle biopsy specimens of pulmonary lesions ≤3 cm in diameter.

Authors:  Jun Matsubayashi; Shinji Miyake; Yujin Kudo; Yoshihisa Shimada; Junichi Maeda; Hisashi Saji; Masatoshi Kakihana; Jinho Park; Naohiro Kajiwara; Shigeru Inoue; Kazuhiro Saito; Tatsuo Ohira; Norihiko Ikeda; Koichi Tokuuye; Toshitaka Nagao
Journal:  Diagn Cytopathol       Date:  2019-04-09       Impact factor: 1.582

Review 8.  Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review.

Authors:  Ying Cao; Li-Zhen Zhu; Meng-Jie Jiang; Ying Yuan
Journal:  Onco Targets Ther       Date:  2015-12-31       Impact factor: 4.147

9.  Early stage lung cancer: pathologist's perspective.

Authors:  Francesca Boggio; Alessandro Del Gobbo; Giorgio Croci; Marco Barella; Stefano Ferrero
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 3.005

10.  Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs.

Authors:  Fei Zhou; Wanrong Ma; Wei Li; Huijuan Ni; Guanghui Gao; Xiaoxia Chen; Jie Zhang; Jingyun Shi
Journal:  BMC Cancer       Date:  2018-10-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.